Weekly Market Insights: Biogen, Zillow, Gap, and More

Nvidia, Microsoft, Apple, Zillow, and Biogen stocks have been discussed by various brokers this week. Biogen's Alzheimer's drug Leqembi is expected to draw more investor attention, leading to a potential stock price increase. US softlines retailers are expected to deliver a mixed performance through the end of 2025, with consumer spending likely to result in a modest holiday season. The UK's Chancellor has announced a steep rise in taxes on online betting and gaming. The US stock market rally may be shifting, with earnings growth spreading beyond tech giants, according to Deutsche Bank's 2026 outlook. Zillow is poised for another quarter of outperformance in Q4, driven by strengthening US housing momentum. Gap Inc's emerging beauty and accessories lines, along with cost discipline and selective store expansion, are expected to drive long-term growth.